BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 853204)

  • 1. Cyclandelate: effect on circulatory measurements and exercise tolerance in chronic arterial insufficiency of the lower limbs.
    Reich T
    J Am Geriatr Soc; 1977 May; 25(5):202-5. PubMed ID: 853204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of cyclandelate in peripheral arterial disease.
    Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
    Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclandelate in the treatment of cerebral arteriosclerosis.
    Hall P
    J Am Geriatr Soc; 1976 Jan; 24(1):41-5. PubMed ID: 811704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclandelate on dementia.
    Westreich G; Alter M; Lundgren S
    Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calf blood flow in intermittent claudication.
    Jacobs S; Reich T
    Arch Surg; 1975 Dec; 110(12):1465-8. PubMed ID: 1200831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic arterial blood pressure during exercise in patients with atherosclerosis obliterans of the lower limbs.
    Lorentsen E
    Circulation; 1972 Aug; 46(2):257-63. PubMed ID: 5046021
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V; Lorentsen E
    Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclandelate in long standing cerebral arteriosclerosis.
    Rogers WF; Shaikh VA; Clark AN
    Gerontol Clin (Basel); 1970; 12(2):88-93. PubMed ID: 4987660
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of cyclandelate in depressed and demented patients: a controlled study in psychogeriatric patients.
    Davies G; Hamilton S; Hendrickson E; Levy R; Post F
    Age Ageing; 1977 Aug; 6(3):156-62. PubMed ID: 331919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice.
    de Halleux F
    Drugs; 1987; 33 Suppl 2():114-9. PubMed ID: 3622305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency].
    Foltyn P; Lücker PW; Schnitker J
    Arzneimittelforschung; 1982; 32(10):1322-8. PubMed ID: 6891235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of emakor in arterial ischemia of the lower extremities in outpatient practice].
    Sviridov AA; Romashkin AV; Terekhova TM; Zadionchenko VS
    Ter Arkh; 1992; 64(1):44-6. PubMed ID: 1355932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans.
    Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific effects of cyclandelate on memory.
    Ananth J
    Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication.
    Sumner DS; Strandness DE
    Surgery; 1969 May; 65(5):763-71. PubMed ID: 5777227
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of early diabetic retinopathy with cyclandelate.
    Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
    Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patients.
    Memin Y
    Drugs; 1987; 33 Suppl 2():120-4. PubMed ID: 3497796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans.
    Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y
    Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone in the treatment of arterial insufficiency of the lower limbs.
    Hentzer E; Madsen PC
    Scand J Clin Lab Invest Suppl; 1967; 99():198-206. PubMed ID: 4862833
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.
    Nappi G; Sandrini G; Savoini G; Cavallini A; de Rysky C; Micieli G
    Drugs; 1987; 33 Suppl 2():103-9. PubMed ID: 3304950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.